Respiratory syncytial virus (RSV) is a leading cause of respiratory ... Here, we describe the epidemiology of RSV, the RSV virion structure, key neutralizing epitopes on the pre- and post-fusion ...

Now, Scripps Research scientists have analyzed the structure and stability of ... prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus," include Yi-Zong ...

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...

About AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) AREXVY contains recombinant RSV glycoprotein F stabilized in the prefusion conformation (RSVPreF3). This antigen is combined with GSK ...

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...

A study reveals that Respiratory Syncytial Virus-associated Acute Respiratory Infection increases death risk in adults. The risk is three times higher within a year. RSV can lead to ...

A study presented at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death within one ...

The Department for Health and Social Care expanded access to the life-saving jab this month to prevent these hospitalisations and the 8,000 deaths linked to respiratory syncytial virus (RSV ...

MANILA, Philippines — Respiratory Syncytial Virus (RSV) is a widespread yet lesser-known respiratory virus — and it is contagious. It transmits through inhalation or contact with respiratory ...

Respiratory syncytial virus (RSV) is a negative-stranded, RNA-based respiratory paramyxovirus with ten genes encoding 11 proteins. Three proteins are present in the viral envelope, including the ...